Corbus Pharmaceuticals Announces Publication of Two
Corbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2021 Virtual Congress Corbus Pharmaceuticals Holdings, Inc. Norwood, Massachusetts, UNITED STATES Norwood, MA, May 25, 2021 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced the publication of two abstracts at the European League Against Rheumatism (EULAR) 2021 Virtual Congress that will be taking place June...
Source: globenewswire.com